Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Tolerance Of Class I Histocompatibility Antigens Expressed Extrathymically

G. Morahan, J. Allison, J. Miller
Published 1989 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
ALTHOUGH convincing evidence has been obtained for the imposition of self-tolerance by the intrathymic deletion of self-reactive T cells1–4, the development of tolerance to antigens which are expressed only in the periphery is not so well understood. We have approached this question by creating transgenic mice5 which carry a class I major histocompatibility complex (MHC) gene (H-2Kb) linked to the rat insulin promoter6. Mice expressing the transgene develop diabetes, but do not appear to mount an immune response against the transgene-expressing pancreaticβ-cells, even when the transgene is allogeneic with respect to the endogenous host H-2 antigens6. We have now explored the mechanism of this tolerance further. We find that spleen cells from pre-diabetic transgenic (RIP-Kb) mice do not kill targets bearing H-2Kb, whereas thymus cells from the same mice do. The unresponsiveness of these spleen cells can be reversed in vitro by providing recombinant interleukin-2 (rIL-2). In older, diabetic mice, responsiveness develops as the pancreatic β-cells are lost. Our results point to an extrathymic mechanism of tolerance induction, dependent on the continuous presence of antigen and the lack of IL-2 in the local environment of potentially reactive T cells.
This paper references
10.1038/336073A0
Positive and negative selection of an antigen receptor on T cells in transgenic mice
W. Sha (1988)
10.1016/S0065-2776(08)60030-9
Function and specificity of T cell subsets in the mouse.
J. Sprent (1987)
10.1111/j.1600-065X.1987.tb00521.x
Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes
T. Braciale (1987)
10.1038/333529A0
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells
J. Allison (1988)
10.1073/PNAS.85.7.2269
Alloreactive immune responses of transgenic mice expressing a foreign transplantation antigen in a soluble form.
B. Arnold (1988)
10.1038/333742A0
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes
P. Kisielow (1988)
10.1016/0092-8674(88)90497-7
Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells
D. Lo (1988)
10.1111/j.1600-065X.1987.tb00523.x
Recognition Requirements for the Activation, Differentiation and Function of T‐Helper Cells Specific for Class I MHC Alloantigens
A. Singer (1987)
10.1016/0167-5699(89)90306-X
Immunological tolerance: new approaches using transgenic mice.
J. Miller (1989)
10.1038/336476A0
Antigen presenting function of class II MHC expressing pancreatic beta cells
J. Markmann (1988)
10.1073/PNAS.86.10.3782
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
G. Morahan (1989)
Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes.
G. Essery (1988)
10.1016/0092-8674(87)90568-X
T cell tolerance by clonal elimination in the thymus
J. Kappler (1987)



This paper is referenced by
10.1016/j.immuni.2008.03.012
Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor.
R. Teague (2008)
10.1093/INTIMM/12.6.817
Impaired Ca/calcineurin pathway in in vivo anergized CD4 T cells.
M. Kimura (2000)
10.1007/978-3-642-83755-5_154
Prospects in transplantation.
P. Morris (1991)
10.1016/S0955-470X(10)80029-1
The veto mechanism in transplant tolerance
J. M. Thomas (1991)
Characterization of dendritic cells transduced with Venezuelan equine encephalitis virus replicon particles as therapeutic cancer vaccines
T. P. Moran (2006)
10.1084/JEM.189.2.265
The Avidity Spectrum of  T Cell Receptor Interactions Accounts for T Cell Anergy in a Double Transgenic Model
L. Girgis (1999)
10.1111/j.1600-065X.1990.tb00819.x
Transgenic Mice as an in vivo Model for Self‐Reactivity
D. Ferrick (1990)
10.4049/jimmunol.164.8.3982
Persistence of Physiological Self Antigen Is Required for the Regulation of Self Tolerance1
K. Garza (2000)
10.1007/BF00195289
Non-obese diabetic transgenic mouse
K. Yamamura (2004)
Immunotolerance against a foreign antigen transgenically expressed in the lens.
J. C. Lai (1998)
10.1038/353566A0
Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes
A. Turnley (1991)
10.1111/j.1600-065X.1991.tb00599.x
A Transgenic Approach to the Study of Peripheral T‐Cell Tolerance
J. Miller (1991)
10.1016/0167-5699(90)90048-E
Cellular signalling in programmed cell death (apoptosis).
D. McConkey (1990)
10.1111/j.1600-065X.1990.tb00808.x
Tolerance in vivo and in vitro
K. Tomonari (1990)
10.1111/j.1365-2567.2007.02793.x
Generation and characterization of transgenic mice expressing a T‐cell receptor specific for the tumour‐associated antigen MDM2
S. Xue (2008)
10.4049/jimmunol.164.6.3065
Vigorous Allograft Rejection in the Absence of Danger1
A. Bingaman (2000)
10.1016/S0369-8114(01)00169-9
Cellules dendritiques et interaction avec d'autres types cellulaires. La tolérance immunitaire
S. Guerder (2001)
10.1016/j.jaut.2010.06.007
The use of mouse models to better understand mechanisms of autoimmunity and tolerance.
F. Miyagawa (2010)
10.1007/978-94-010-0981-2_3
The physiological role of regulatory T cells in the prevention of autoimmunity: generation, specificity and mode of action.
B. Seddon (2000)
10.1007/BF02918299
Self-nonself discrimination and tolerance in T and B lymphocytes
J. Miller (1993)
10.1007/978-3-642-75239-1_9
Major histocompatibility complex molecules and the beta cell: inferences from transgenic models.
J. Allison (1990)
10.1016/0008-8749(91)90092-P
Lymphocytes in thymomas are tolerant to self-MHC.
Y. Fujii (1991)
10.1016/B978-0-12-596922-2.50007-1
CHAPTER 3 – Experimental Models of Human Autoimmune Disease: Overview and Prototypes
C. Bernard (1992)
10.1111/j.1600-065X.1991.tb00596.x
Non‐Deletional Mechanisms of Peripheral and Central Tolerance: Studies with Transgenic Mice with Tissue‐Specific Expression of a Foreign MHC Class I Antigen
Günter J. Hammerxing (1991)
10.1038/359547A0
Autoimmune diabetes as a consequence of locally produced interleukin-2
W. Heath (1992)
10.1084/JEM.173.5.1235
Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system
J. Sedgwick (1991)
10.1016/J.FREERADBIOMED.2004.11.001
Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading.
R. H. Scofield (2005)
10.1172/JCI114331
Tolerance induced by physiological levels of secreted proteins in transgenic mice expressing human insulin.
P. Whiteley (1989)
10.1016/S0198-8859(96)00287-X
Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.
R. Hunziker (1997)
10.1007/BF02918301
T cell repertoire and autoimmune diseases
L. Imberti (1993)
10.1111/j.1600-065X.1993.tb01511.x
Peripheral Tolerance as a Multi‐Step Mechanism
G. Hämmerling (1993)
Effects of Long-Term Exposure of Normal C57bl/6j Inbred Mice to 17beta-Estradiol on Gene Expression in Lymphocytes: Mrna Analysis of Lymphokines and Bcl-2/Fas
Z. Yin (1997)
See more
Semantic Scholar Logo Some data provided by SemanticScholar